Wacker Chemie (WCH) Investor presentation summary

Company overview and strategy

• Operates 27 production sites globally, with €5.7bn sales and 16,637 employees as of Dec. 2024.

• Strategic focus on specialty business expansion, sustainability, semiconductor-grade polysilicon, biotech, and digitalization.

• Holds leading market positions: #1 in semiconductor polysilicon and polymers, #2 in silicones, and niche leadership in biosolutions.

• Over 60% of sales generated outside Europe, with strong presence in Asia and the Americas.

• Highly integrated operations based on five key raw materials, serving diverse end markets including construction, electronics, healthcare, and energy.

Financial performance and capital allocation

• 2024 sales reached €5.7bn with EBITDA of €744m and a 13.0% margin; ROCE at 5.0%.

• Maintains a solid capital structure with €4.8bn in equity and low financial debt; net debt/EBITDA target at ~1.0x.

• Dividend policy targets ~50% payout of net income; €1.4bn paid over the past five years.

• Flexible CapEx program supports growth and resilience, with investments aligned to market conditions.

Segment highlights

• Silicones: Over 85% of sales in specialties, focusing on sustainable solutions for construction, e-mobility, energy, and healthcare.

• Polymers: Market leader in VAE/DPP, driving transformation in construction and consumer markets with sustainable, high-performance binders.

• Biosolutions: Fast-growing biotech business, leveraging CDMO trends and advanced microbial technologies for biopharma and food ingredients.

• Polysilicon: Extends #1 position in high-end semiconductors, investing in new fabs and targeting growth in PV solar outside China.